Upadacitinib
Drug timelines are a Plus or Pro feature.
98 regulatory and trial events tracked for Upadacitinib, covering 2019-10-04 to 2026-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]